ArticleJournal of geriatric oncology2012

Is Age ≥ 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic Trials.

Aminah Jatoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.